Advancing Male Fertility Care: Scientific Presentations in Spring 2025

Kristin Brogaard, PhD, (speaking) Co-founder & CSO, Path Fertility a division of Inherent Biosciences

This spring, we continued to advance the conversation around male infertility by presenting breakthrough innovations and real-world clinical data at five leading reproductive medicine conferences across the country. From coast to coast, our team connected with fertility specialists, researchers, and clinical partners to share how our breakthrough diagnostics, SpermQT and NOA guide, are reshaping the way fertility is diagnosed and treated.

Sharing the Science at Leading Conferences

We were honored to present at the following Spring 2025 events, each offering a unique platform to engage with leaders in reproductive health:


Pacific Coast Reproductive Society (PCRS) Annual Meeting

Rancho Mirage, CA
We presented two scientific posters:

  • Economic Evaluation of Integrating an Epigenetic and Comprehensive Male Infertility Assessment

  • Real-World Assessment of Epigenetic Sperm Quality Testing for Predicting Fertility Treatment Success: A Multi-Site Analysis of 537 Patients

American Society of Andrology (ASA) Annual Meeting

Boston, MA
Our poster presentation focused on a breakthrough for male patients with the most severe form of infertility, non-obstructive azoospermia (no sperm):

  • Single-Molecule Native Sequencing of Cell-Free DNA in Seminal Plasma Predicts Success of Sperm Extraction Procedures

American Urological Association (AUA) Annual Meeting

Chicago, IL
Our clinical research collaborator, Blair Stocks MD PhD, delivered an oral presentation highlighting predictive accuracy in complex male infertility:

  • A Non-Invasive Predictor of Sperm Retrieval Success in Men with Non-Obstructive Azoospermia (NOA)

AAB/CRB Annual Meeting (American Association of Bioanalysts / College of Reproductive Biology)

Las Vegas, NV
Our Chief Scientific Officer, Kristin Brogaard, PhD presented a keynote covering the molecular impact of methylation:

  • SpermQT – Impact of Methylation on Fertilization

U.S. Fertility Centers of Practice Summit (COPS)

San Diego, CA
We were proud to participate in three invited oral presentations:

  • Innovation Initiatives Across US Fertility

  • Emerging Trends in Reproductive Urology

  • SPOT Clinical Trial Interim Results (physician breakout session)


Looking Ahead: Let’s Transform Fertility Care Together

At Path Fertility, we’re committed to raising the standard of care in male reproductive health. From non-invasive diagnostics to clinical outcome prediction, our work is making fertility treatment more effective, personalized, and equitable for all patients.

If you're a fertility clinic, physician, or health system interested in our diagnostics or collaborating on clinical research, we’d love to connect. Together, we can close the diagnostic gap and improve outcomes for couples facing infertility.

📩 Reach out to explore partnership opportunities.

Next
Next

Path Fertility’s Progress Highlighted at Biotech Showcase 2025